News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
694,348 Results
Type
Article (39461)
Company Profile (247)
Press Release (654640)
Section
Business (204073)
Career Advice (2006)
Deals (35416)
Drug Delivery (93)
Drug Development (80976)
Employer Resources (170)
FDA (16145)
Job Trends (14835)
News (344969)
Policy (32483)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2545)
Accelerated approval (2)
Adcomms (20)
Allergies (78)
Alliances (49343)
ALS (75)
Alzheimer's disease (1325)
Antibody-drug conjugate (ADC) (99)
Approvals (16130)
Artificial intelligence (212)
Autoimmune disease (10)
Automation (14)
Bankruptcy (359)
Best Places to Work (11636)
BIOSECURE Act (18)
Biosimilars (94)
Biotechnology (175)
Bladder cancer (50)
Brain cancer (24)
Breast cancer (238)
Cancer (1822)
Cardiovascular disease (138)
Career advice (1671)
Career pathing (28)
CAR-T (132)
Cell therapy (378)
Cervical cancer (13)
Clinical research (65469)
Collaboration (714)
Compensation (416)
Complete response letters (18)
COVID-19 (2574)
CRISPR (33)
C-suite (189)
Cystic fibrosis (97)
Data (1769)
Decentralized trials (2)
Denatured (14)
Depression (36)
Diabetes (227)
Diagnostics (6306)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (107)
Drug pricing (94)
Drug shortages (25)
Duchenne muscular dystrophy (69)
Earnings (85818)
Editorial (30)
Employer branding (21)
Employer resources (146)
Events (111299)
Executive appointments (602)
FDA (17140)
Featured Employer (48)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (636)
Gene editing (90)
Generative AI (18)
Gene therapy (263)
GLP-1 (664)
Government (4369)
Grass and pollen (4)
Guidances (47)
Healthcare (18809)
Huntington's disease (22)
IgA nephropathy (20)
Immunology and inflammation (92)
Indications (23)
Infectious disease (2695)
Inflammatory bowel disease (128)
Inflation Reduction Act (8)
Influenza (43)
Intellectual property (72)
Interviews (311)
IPO (16479)
IRA (40)
Job creations (3628)
Job search strategy (1421)
Kidney cancer (9)
Labor market (29)
Layoffs (442)
Leadership (14)
Legal (7894)
Liver cancer (70)
Lung cancer (266)
Lymphoma (123)
Machine learning (2)
Management (58)
Manufacturing (252)
MASH (57)
Medical device (13294)
Medtech (13299)
Mergers & acquisitions (19361)
Metabolic disorders (593)
Multiple sclerosis (60)
NASH (16)
Neurodegenerative disease (70)
Neuropsychiatric disorders (23)
Neuroscience (1764)
NextGen: Class of 2025 (6510)
Non-profit (4476)
Northern California (2254)
Now hiring (36)
Obesity (327)
Opinion (197)
Ovarian cancer (61)
Pain (71)
Pancreatic cancer (70)
Parkinson's disease (122)
Partnered (17)
Patents (184)
Patient recruitment (85)
Peanut (45)
People (56961)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20385)
Phase II (28834)
Phase III (21480)
Pipeline (836)
Podcasts (40)
Policy (102)
Postmarket research (2563)
Preclinical (8597)
Press Release (64)
Prostate cancer (86)
Psychedelics (30)
Radiopharmaceuticals (242)
Rare diseases (342)
Real estate (5898)
Recruiting (65)
Regulatory (22027)
Reports (43)
Research institute (2315)
Resumes & cover letters (349)
Rett syndrome (3)
RNA editing (2)
RSV (37)
Schizophrenia (61)
Series A (114)
Series B (69)
Service/supplier (11)
Sickle cell disease (49)
Southern California (1937)
Special edition (14)
Sponsored (28)
Startups (3569)
State (2)
Stomach cancer (12)
Supply chain (57)
The Weekly (25)
United States (19824)
Vaccines (636)
Venture capitalists (35)
Webinars (12)
Weight loss (220)
Women's health (30)
Worklife (14)
Date
Today (139)
Last 7 days (608)
Last 30 days (2933)
Last 365 days (34035)
2025 (6224)
2024 (35217)
2023 (40076)
2022 (51184)
2021 (55717)
2020 (54083)
2019 (46542)
2018 (35019)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (717)
Alabama (48)
Alaska (7)
Arizona (214)
Arkansas (12)
Asia (37587)
Australia (6146)
California (5141)
Canada (1787)
China (420)
Colorado (236)
Connecticut (248)
Delaware (115)
Europe (80620)
Florida (763)
Georgia (177)
Idaho (57)
Illinois (467)
India (22)
Indiana (279)
Iowa (7)
Japan (129)
Kansas (99)
Kentucky (23)
Louisiana (7)
Maine (60)
Maryland (789)
Massachusetts (3902)
Michigan (205)
Minnesota (352)
Mississippi (2)
Missouri (72)
Montana (27)
Nebraska (25)
Nevada (54)
New Hampshire (61)
New Jersey (1464)
New Mexico (27)
New York (1473)
North Carolina (880)
North Dakota (7)
Northern California (2254)
Ohio (181)
Oklahoma (13)
Oregon (32)
Pennsylvania (1172)
Puerto Rico (6)
Rhode Island (24)
South America (1093)
South Carolina (15)
South Dakota (1)
Southern California (1937)
Tennessee (86)
Texas (759)
Utah (158)
Virginia (119)
Washington D.C. (56)
Washington State (493)
West Virginia (3)
Wisconsin (45)
694,348 Results for "mentice inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Mentice Receives Grant from Sweden’s Innovation Agency to Improve Synthetic Image Generation
Mentice has received a 3 million SEK grant from the Swedish government agency for innovation, Vinnova, to improve realism in Mentice virtual reality software environment with a focus on synthetic image generation.
November 9, 2022
·
1 min read
Business
Mentice and Acandis GmbH announce a 3-year agreement for Mentice Ankyras clinical support software solutions at a value of 8.9mSEK
Mentice AB (publ), Gothenburg, a world leader in simulation solutions for image-guided interventional therapies, announced today that Acandis, Pforzheim, a leading innovator of minimal invasive devices for the treatment of neurovascular diseases, has signed a 3-year collaboration agreement to further develop the Acandis clinical support platform and supply their customers with Mentice Ankyras clinical support software solutions.
October 25, 2022
·
3 min read
Deals
Mentice AB (STO: MNTC) completes the acquisition of ANKYRAS
Mentice AB (STO: MNTC) (“Mentice”) Mentice today confirms the acquisition of the Ankyras business from Galgo Medical SL, as previously communicated via the press release on 9th June 2022, now has been completed.
June 30, 2022
·
1 min read
Mentice AB (publ) receives an order of USD 620,000 for simulation solutions and development services
Mentice AB, Gothenburg announced that a leading global healthcare technology company, has signed an agreement to acquire Mentice VIST® simulation solutions and development services, for an order of USD 620,000.
September 23, 2022
·
2 min read
Mentice AB (publ) receives an order of USD 540,000 for simulation solutions from Corewell Health, Grand Rapids, Michigan, USA
Mentice AB, Gothenburg, a world leader in simulation solutions for image-guided interventional therapies, announced that Corewell Health, Grand Rapids, Michigan USA, has signed an agreement to acquire Mentice VIST® simulation solutions for an order of USD 540,000.
December 30, 2022
·
1 min read
Business
Mentice publishes the company’s interim report for the period April - June 2022
During the second quarter Mentice acquired the assets of Ankyras from Galgo Medical. Ankyras develops applications for precision medicine and will take Mentice into the operating room with a regulatory approved solutions assisting physicians in their aim to improve the outcome for patients.
July 21, 2022
·
3 min read
Deals
Mentice AB (publ) receives an order of 1,1 million USD for simulation solutions from Beijing Huanya Zhitong on behalf of the Chinese Medical Education Association.
Mentice AB (publ), Gothenburg, a world leader in simulation solutions for image-guided interventional therapies, announced today that Beijing Huanya Zhitong, Beijing, China, has signed an agreement to acquire Mentice VIST® simulation solutions for an order of 1,1 million USD.
December 19, 2022
·
1 min read
Press Releases
electroCore, Inc. Announces Agreement with Spark Biomedical Inc. to Distribute Sparrow Ascent for Opioid Withdrawal
February 27, 2025
·
4 min read
Business
Siemens Healthineers to include Mentice VIST ® simulators with Corindus CorPath GRX Robotic PCI system (CorPath GRX) in China
Mentice and Siemens Healthineers China announce that Mentice VIST ® Virtual Patient simulators will be included with the sale of every Corindus CorPath GRX Robotic system (CorPath GRX) in China on an initial 3-year agreement, starting 2022.
December 27, 2021
·
3 min read
Mentice receives an initial order of USD 1.93million for simulation solutions and development services from Medtronic
Mentice, Gothenburg, a world leader in simulation solutions for image-guided interventional therapies, announced that Medtronic, Dublin, a global healthcare technology leader, has signed an agreement to acquire Mentice VIST® simulation solutions and development services, in an initial order of USD 1.93 million.
June 29, 2022
·
1 min read
1 of 69,435
Next